TheraRadar
Clinical-Stage Companies / Therapeutics

Therapeutics

Pre-Approval PRO BETA
🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 2/17/2022

17
Total Trials
7
Phase 3
9
Phase 2
0
Recruiting
180
Score

Pipeline by Phase

Phase 3
7
Phase 2
9
Phase 1
1

Therapeutic Focus

Plaque Psoriasis Tinea Pedis Psoriasis Tinea Cruris Scalp Psoriasis

Clinical Trials (17)

NCT03731052 Phase 3 COMPLETED

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

Started: 10/16/2018

NCT03759197 Phase 3 COMPLETED

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

Started: 11/26/2018

NCT02368210 Phase 3 COMPLETED

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)

Started: 1/1/2015

NCT02742441 Phase 3 COMPLETED

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

Started: 6/1/2016

NCT02367911 Phase 3 COMPLETED

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis

Started: 1/1/2015

NCT01882647 Phase 3 COMPLETED

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)

Started: 6/1/2013

NCT01871402 Phase 3 COMPLETED

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)

Started: 5/1/2013

NCT03897257 Phase 2 COMPLETED

A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis

Started: 3/15/2019

NCT04080206 Phase 2 COMPLETED

A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis

Started: 4/7/2020

NCT04243486 Phase 2 COMPLETED

A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis

Started: 1/2/2020

NCT03307577 Phase 2 COMPLETED

A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris

Started: 10/5/2017

NCT01700985 Phase 2 COMPLETED

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

Started: 5/1/2012

NCT01698333 Phase 2 COMPLETED

Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression

Started: 4/1/2012

NCT03065556 Phase 2 COMPLETED

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

Started: 1/26/2017

NCT01166646 Phase 2 COMPLETED

Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

Started: 7/1/2010

NCT01610596 Phase 2 COMPLETED

A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis

Started: 11/1/2011

NCT05363449 Phase 1 COMPLETED

Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Started: 2/17/2022

Drug Candidates

UHE-103 Cream Naftin (naftifine hydrochloride) Cream UHE-103A1 cream UHE-103A2 cream UHE-103B cream UHE-103A1B cream UHE-103A2B cream 188-0551 Spray RLD UHE-105
Activity Status: Stale
Last Trial Started: 2/17/2022
Last Trial Ended: 11/14/2023
Trials (12 months): 0
Completed Trials: 17
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.